NIR-II J-Aggregated Pt(II)-Porphyrin-Based Phosphorescent Probe for Tumor-Hypoxia Imaging.
Wansu ZhangShangyu ChenPengfei SunShuai YeQu-Li FanJun SongPengju ZengJunle QuWai Yeung WongPublished in: Advanced healthcare materials (2022)
The luminescence of traditional phosphorescence-based hypoxia probes is limited to the visible and first near-infrared wavelength regions (<1000 nm), which has defects of higher light scattering and lower penetration depth in contrast with the second near-infrared wavelength window (NIR-II, 1000-1700 nm) for optical bioimaging. Herein, 5,15-bis(2,6-bis(dodecyloxy)phenyl)-porphyrin platinum(II) (PpyPt) with J-aggregation induced NIR-II phosphorescence is reported. J-aggregates of PpyPt are confirmed by the X-ray diffraction data in the crystalline state. Moreover, the emission and excitation spectra of PpyPt in the solid states reveal NIR-II luminescence feature of PpyPt in J-aggregates. More importantly, by preparation of water-soluble PpyPt nanoparticles (PpyPt NPs 4.76 ) with J-aggregates, it has NIR-II phosphorescent lifetime of microseconds and good oxygen-sensitivity in water. Moreover, the good biological hypoxia-sensing potential of PpyPt NPs 4.76 is demonstrated in cells and 4T1-tumor-bearing mice. This study provides an efficient strategy to design NIR-II phosphorescent probe for sensitive tumor-hypoxia detection through the construction of J-aggregates.
Keyphrases
- photodynamic therapy
- fluorescence imaging
- fluorescent probe
- living cells
- quantum dots
- drug release
- high resolution
- gene expression
- room temperature
- computed tomography
- drug delivery
- ionic liquid
- energy transfer
- insulin resistance
- adipose tissue
- metabolic syndrome
- mass spectrometry
- oxidative stress
- electronic health record
- cell cycle arrest
- single cell
- high speed
- contrast enhanced
- liquid chromatography
- high density
- loop mediated isothermal amplification